Alzheimer’s disease (AD) is characterized by beta-amyloid accumulation, phosphorylated tau formation, chronic hyperactivation of glial cells, and neuronal loss (Serrano-Pozo et al., 2011; Nirzhor et al., 2018). The gene discussed is MAPT; the disease is Alzheimer disease.